NCT06336733View on ClinicalTrials.gov

Randomized Controlled Trial in Patients on Long-term Colchicine With Colchicine-resistant Familial Mediterranean Fever (FMF) to Evaluate the Efficacy of On-demand Anakinra Treatment for Painful Attacks in Patients Who Refuse Continuous Daily Therapy

PHASE3RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 4, 2024

Primary Completion Date

December 4, 2026

Study Completion Date

December 4, 2026

Conditions

FMF

Interventions

DRUG

ANAKINRA

On demand Anakinra 100 mg/j from the prodromal phase of the attack until 24 hours of remission (during 7 days maximum) + colchicine + on demand analgesics

Trial Locations (1)

75020

RECRUITING

Service de Médecine interne Hopital Tenon, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER